GlassScriptPhysician profile
Edwin Walter Wager
NPI 1558326587
$556.19
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $203.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $96.10 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.66 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $63.41 | 2019 | |
| Pfizer INC. | $52.70 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $48.73 | 2019-2020 | |
| Allergan, INC. | $37.92 | 2019-2020 | |
| Novo Nordisk INC | $30.30 | 2020 | |
| Amag Pharmaceuticals, INC. | $24.46 | 2019 | |
| Amgen INC. | $21.19 | 2020 | |
| Vertical Pharmaceuticals, LLC | $20.99 | 2019 | |
| Assertio Therapeutics, INC. | $16.92 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.77 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.33 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.59 | 2019 | |
| Alfasigma USA, INC. | $13.12 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Wager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.